Showing results (1-10 of 105) with videos related to
Sort By:
Pageof 11
Drug Discovery Today|June 17, 2023
Clinical research with targeted drugs in paediatric oncologyPaula Valle-Simón, Alberto M Borobia, Antonio Pérez-MartínezJournal of Clinical Medicine|April 3, 2021
Valproic Acid-Induced Liver Injury: A Case-Control Study from a Prospective Pharmacovigilance Program in a Tertiary HospitalEnrique S Meseguer, Mikel U Elizalde, Alberto M Borobia, et al.Expert Review of Clinical Pharmacology|December 13, 2023
Implementing pharmacogenetics in clinical trials: considerations about current methodological, ethical, and regulatory challengesIrene García-García, Enrique Seco-Meseguer, Alberto M Borobia, et al.Clinical and Translational Science|October 27, 2023
Evaluation of factors associated with recruitment rates in early phase clinical trials based on the European Clinical Trials Register dataPaloma Moraga Alapont, Paula Prieto, Mikel Urroz, et al.Basic & Clinical Pharmacology & Toxicology|May 27, 2015
Non-Chemotherapy-Induced Agranulocytosis Detected by a Prospective Pharmacovigilance Program in a Tertiary HospitalNicolás Medrano-Casique, Hoi Y Tong, Alberto M Borobia, et al.Case Reports in Pediatrics|February 18, 2015
Liver Transplant in a Patient under Methylphenidate Therapy: A Case Report and Review of the LiteratureHoi Y Tong, Carmen Díaz, Elena Collantes, et al.Pediatric Hematology and Oncology|December 7, 2016
Nonchemotherapy drug-induced agranulocytosis in children detected by a prospective pharmacovigilance programNicolás Medrano-Casique, Hoi Y Tong, Alberto M Borobia, et al.European Journal of Pharmacology|October 21, 2009
Evaluation of the influence of sex and CYP2C19 and CYP2D6 polymorphisms in the disposition of citalopramSalvador Fudio, Alberto M Borobia, Enrique Piñana, et al.Plos One|April 22, 2016
Outcomes and Costs of Poisoned Patients Admitted to an Adult Emergency Department of a Spanish Tertiary Hospital: Evaluation through a Toxicovigilance ProgramRaúl Muñoz, Alberto M Borobia, Manuel Quintana, et al.Trials|August 8, 2020
A phase II, single-center, double-blind, randomized placebo-controlled trial to explore the efficacy and safety of intravenous melatonin in patients with COVID-19 admitted to the intensive care unit (MelCOVID study): a structured summary of a study protocol for a randomized controlled trialMiguel Rodríguez-Rubio, Juan Carlos Figueira, Darío Acuña-Castroviejo, et al.Pageof 11